Role of thiamine in Alzheimer's disease (Q37973263)

26 August 2017

Role of thiamine in Alzheimer's disease (English)

1 reference

26 August 2017

0 references

Khanh vinh quoc Lu'o'ng

series ordinal

1

1 reference

PubMed ID

22218733

26 August 2017

Lan Thi Hoang Nguyen

series ordinal

2

1 reference

PubMed ID

22218733

26 August 2017

language of work or name

English

0 references

publication date

1 December 2011

1 reference

American Journal of Alzheimer's Disease & Other Dementias

26 August 2017

1 reference

26 August 2017

26

1 reference

26 August 2017

588-598

1 reference

26 August 2017

8

1 reference

Tricarboxylic acid cycle enzymes following thiamine deficiency

26 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Plasma and red blood cell thiamine deficiency in patients with dementia of the Alzheimer's type

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Reduced Activities of Thiamine-Dependent Enzymes in the Brains and Peripheral Tissues of Patients With Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Studies of Transketolase Abnormality in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Occurrence of transketolase abnormalities in extracts of foreskin fibroblasts from patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Characteristic transketolase alterations in dermal fibroblasts of Alzheimer patients are modulated by culture conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Molecular genetics of transketolase in the pathogenesis of the Wernicke-Korsakoff syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Abnormality of a thiamine-requiring enzyme in patients with Wernicke-Korsakoff syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Transketolase abnormality in cultured fibroblasts from familial chronic alcoholic men and their male offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Individual susceptibility to Wernicke-Korsakoff syndrome and alcoholism-induced cognitive deficit: impaired thiamine utilization found in alcoholics and alcohol abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

alpha-1-Antichymotrypsin polymorphism in the gene promoter region affects survival and synapsis loss in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Genetic polymorphisms in apolipoprotein E and glutathione peroxidase 1 genes in the Ecuadorian population affected with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Apolipoprotein E epsilon 4 allele distribution in Wernicke-Korsakoff syndrome with or without global intellectual deficits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Plasma biomarkers for mild cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Strategies for dissecting genetic-environmental interactions in neurodegenerative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Art, alpha-1-antitrypsin polymorphisms and intense creative energy: blessing or curse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Characterization of a missense mutation at histidine-44 in a pyruvate dehydrogenase-deficient patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Thiamine-responsive pyruvate dehydrogenase deficiency in two patients caused by a point mutation (F205L and L216F) within the thiamine pyrophosphate binding region

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

21 January 2018

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Conformationally altered p53: a novel Alzheimer's disease marker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Identification of a mutant-like conformation of p53 in fibroblasts from sporadic Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

NAD+ modulates p53 DNA binding specificity and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

The GSK3 hypothesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Exposure to pyrithiamine increases β-amyloid accumulation, Tau hyperphosphorylation, and glycogen synthase kinase-3 activity in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Activation of c-Fos contributes to amyloid beta-peptide-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Quantitative neuronal c-fos and c-jun expression in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Mechanisms of neuronal cell death in Wernicke's encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Immediate-early gene expression in the brain of the thiamine-deficient rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Glucose induced IEG expression in the thiamin-deficient rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Characterization of the 5'-regulatory region of the human thiamin transporter SLC19A3: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Transcription factor Sp1 dysregulation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Sp1 and Smad transcription factors co-operate to mediate TGF-beta-dependent activation of amyloid-beta precursor protein gene transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Novel systemic markers for patients with Alzheimer disease? - a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Interaction between poly(ADP-ribose) polymerase 1 and interleukin 1A genes is associated with Alzheimer's disease risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Evaluation of the poly(ADP-ribose) polymerase-1 gene variants in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Protective role of benfotiamine, a fat-soluble vitamin B1 analogue, in lipopolysaccharide-induced cytotoxic signals in murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Beta-amyloid enhances glial glutamate uptake activity and attenuates synaptic efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Neurofibrillary tangles in chronic alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Accumulation of amyloid precursor protein-like immunoreactivity in rat brain in response to thiamine deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Microglia and inflammation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Loss of astrocytic glutamate transporters in Wernicke encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Selective response of various brain cell types during neurodegeneration induced by mild impairment of oxidative metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Early microglial response in experimental thiamine deficiency: an immunohistochemical analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Induction of nitric oxide synthase and microglial responses precede selective cell death induced by chronic impairment of oxidative metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

The cholinergic hypothesis of Alzheimer's disease: a review of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Presynaptic cholinergic dysfunction in patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Alterations in cholinergic and non‐cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with β‐amyloid plaque pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Effects of pyrithiamin and oxythiamin on acetylcholine levels and utilization in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Evidence for a central cholinergic effect of high-dose thiamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Memory impairment in Korsakoff's psychosis: a correlation with brain noradrenergic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Thiamine deficiency depletes cortical norepinephrine and impairs learning processes in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Vesicular dysfunction during experimental thiamine deficiency is indicated by alterations in dopamine metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

The medial temporal lobe memory system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Synaptic vesicle transport and synaptic membrane transporter sites in excitatory amino acid nerve terminals in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Beta-amyloid prevents excitotoxicity via recruitment of glial glutamate transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

The amyloid pathology progresses in a neurotransmitter-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Fibroblast glutamate transport in aging and in AD: correlations with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Thiamine deficiency results in downregulation of the GLAST glutamate transporter in cultured astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Selective down-regulation of the astrocyte glutamate transporters GLT-1 and GLAST within the medial thalamus in experimental Wernicke's encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Neuronal histamine deficit in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Effects of histaminergic drugs on muricide induced by thiamine deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Thiamine therapy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Thiamine and Alzheimer's disease. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Preliminary findings of high-dose thiamine in dementia of Alzheimer's type

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

A trial of thiamine in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Chronic treatment with sulbutiamine improves memory in an object recognition task and reduces some amnesic effects of dizocilpine in a spatial delayed-non-match-to-sample task

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Chronic administration of sulbutiamine improves long term memory formation in mice: possible cholinergic mediation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Effects of the association of sulbutiamine with an acetylcholinesterase inhibitor in early stage and moderate Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Adult hypophosphatasia and a low level of red blood cell thiamine pyrophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Influence of age on duodenal brush border membrane and specific activities of brush border membrane enzymes in Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

Kinetics of thiamin and thiamin phosphate esters in human blood, plasma and urine after 50 mg intravenously or orally

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317511432736

21 January 2018

Identifiers

DOI

10.1177/1533317511432736

1 reference

26 August 2017

1 reference

PubMed ID

22218733